NASDAQ · Biotechnology

ARQT (ARQT) Stock

$27.84 +1.79% NASDAQ: ARQT Healthcare

Valuation

MetricValue
Price$27.84
Market Cap$3.48B
P/E Ratio-158.54
P/B Ratio13.64
P/S Ratio6.28
EPS (TTM)$0.00
52-Week High$31.77
52-Week Low$13.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-8.47%
ROA-3.70%
ROCE-6.32%
Gross Margin-3.19%
Operating Margin-3.19%
Net Margin-0.57%
Debt/Equity0.07
Current Ratio3.16

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$4.0M$60.0M$197.0M$376.0M
Operating Profit$-207.0M$-302.0M$-241.0M$-128.0M$-12.0M
Net Profit$-206.0M$-311.0M$-262.0M$-140.0M$-16.0M
EPS$-4.17$-5.66$-3.78$-1.16$-0.13
Op Margin—-8183.0%-404.5%-65.3%-3.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$408.0M$449.0M$341.0M$349.0M$433.0M
Total Liabilities$110.0M$240.0M$253.0M$191.0M$243.0M
Cash$98.0M$54.0M$88.0M$71.0M$43.0M
Borrowings$78.0M$203.0M$206.0M$111.0M$6.0M

Latest News

Dow Jones Futures: Micron, Sandisk, Google Lead AI Sell-Off, Netflix Dives Late; SpaceX Starship Launch Scrubbed Investor's Business Daily · Jul 17, 2026 Lemonade To Announce Second Quarter 2026 Financial Results PR Newswire · Jul 17, 2026 2 Reasons to Like BDC (and 1 Not So Much) StockStory · Jul 17, 2026 Taco Bell removes lettuce in some states over cyclosporiasis link Reuters · Jul 17, 2026 Brookfield Wealth Solutions Announces Shareholder Approval of Transaction to Simplify Corporate Structure and Results of 2026 Annual General and Special Meeting GlobeNewswire · Jul 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-175.0M$-258.0M$-247.0M$-112.0M$-6.0M
Investing Cash Flow$-77.0M$-110.0M$180.0M$29.0M$-31.0M
Financing Cash Flow$0$1.0M$2.0M$5.0M$0
Net Cash Flow$31.0M$-43.0M$34.0M$-17.0M$-29.0M
Free Cash Flow$-176.0M$-281.0M$-247.0M$-112.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield1.03%
Quick Ratio2.46
Interest Coverage-1.00
Return 1Y91.89%
Return 3Y166.16%
Return 5Y14.52%

Ownership

Insiders Held1.79%
Institutions Held110.25%
Institutions Float Held112.27%
Institutional HolderSharesReport Date
Suvretta Capital Management, LLC12,327,0002026-03-31
Frazier Life Sciences Management, L.P. 9,874,5112026-03-31
Blackrock Inc.9,200,4112026-03-31
Rubric Capital Management LP8,271,5772026-03-31
State Street Corporation6,296,1972026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CELC $92.49 +5.44% -91.68 $4.51B 0.00%
CGON $72.17 -1.84% -26.72 $6.37B 0.00%
CNTACentessa Pharmaceuticals plc $40.50 +0.00% -22.75 $6.27B 0.00%
FOLDAmicus Therapeutics Inc $14.49 +0.00% -161.00 $4.55B 0.00%
IRON $73.86 -1.01% -9.08 $2.82B 0.00%

About ARQT

ARQT stock trades at $27.84 with a market capitalization of $3.48B. The stock is valued at a price-to-earnings (P/E) ratio of -158.54, price-to-book of 13.64, price-to-sales of 6.28. Over the past 52 weeks the stock has ranged between $13.06 and $31.77, and currently trades 12.4% below its 52-week high.

On profitability, ARQT generates a return on equity (ROE) of -8.47%, return on capital employed of -6.32%, an operating margin of -3.19%, a net profit margin of -0.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides